Asymmetric cortical high signal on diffusion weighted-MRI in a case of Creutzfeldt-Jakob disease

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 2 B, 2005, Pages 519-522

  Nitrini, Ricardo ^a,c   Areza Fegyveres, Renata ^a   Martins, Vilma R ^b   Castro, Rosa Maria R P S ^b   Landemberger, Michele C ^b   Huang, Nancy ^a   Bacheschi, Luiz A ^a   Bacheschi, Luiz E ^a   Leite, Cláudia C ^a   Buchpiguel, Carlos A ^a   Rosemberg, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c NONE   (Brazil)

Author keywords

Creutzfeldt Jakob disease; Diffusion weighted MRI; MRI; Prion disease

Indexed keywords

METHIONINE; PRION PROTEIN; PROTEIN 14 3 3;

ADULT; ARTICLE; BASAL GANGLION; BRAIN BIOPSY; BRAIN CORTEX; CASE REPORT; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CINGULATE GYRUS; CODON; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MARKER; DNA DETERMINATION; ELECTROENCEPHALOGRAM; GENE INSERTION; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LEFT HEMISPHERE; MALE; PRION DISEASE; RIGHT HEMISPHERE;

EID: 21744436290     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2005000300028     Document Type: Article

References (21)

1. WHO. Report of the consultation on the global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. Geneva: WHO, 1998.
2. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
3. Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 analysis. Neurology 2004;63:410-411.
4. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930.
5. Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R. Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet 1997;349:847-848.
6. Castro RMRPS, Lamdenberger MC, Waltz R, et al. High capacity and low cost detection of prion protein gene variant alleles through denaturing HPLC methodology. J Neurosc Meth 2004;62:751-755.
7. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.
8. Castellani, RJ, Colucci M, Xie Z, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004;63:436-442.
9. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449.
10. Yee AS, Simon JH, Anderson CA, Sze CI, Filley CM, Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology 1999;52:1514-1515.
11. Tribl GG, Strasser G, Zeitlhofer J, et al. Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology 2002;44:223-226.
12. Cambier DM, Kantarci K, Worrell GA, Westmoreland BF, Aksamit AJ. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol 2003;114:1724-1728.
13. Bavis J, Reynolds P Tegeler C, Clark P, Asymmetric neuroimaging in Creutzfeldt-Jakob disease. J Neuroimaging 2003;13:376-379.
14. Mao-Draayer Y, Braff SP, Nagle KJ, Pendlebury W, Penar PL, Shapiro RE. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. Am J Neuroradiol 2002;23:550-556.
15. Tsuji Y, Kanamori H, Murakami G, et al. Heidenhain variant of Creutzfeldt-Jakob disease: diffusion-weighted MRI and PET characteristics. J Neuroimaging 2004;14:63-66.
16. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767-778.
17. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotype analysis of 300 subjects. Ann Neurol 1999;46:224-233..
18. Meissner B, Köhler K, Körtner K, et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 2004; 63:450-456.
19. Samman I, Schulz-Schaeffer WJ, Wohrle JC, Sommer A, Kretzschmar HA, Hennerici M. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. J Neurol Neurosurg Psychiatry 1999;67:678-681.
20. Fukushima R, Shiga Y, Nakamura M, Fujimori J, Kitamoto T, Yoshida Y. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan. J Neurol Neurosurg Psychiatry 2004;75:485-487.
21. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiology 2003;24:1560-1569